Medical devices company, Biocomposites, has announced the addition of STIMULAN, a precision engineered absorbable calcium sulfate product, to the NHS Supply Chain’s Total Orthopaedic Solutions 2 (“TOS2”) framework agreement.
NHS Supply Chain manages the sourcing, delivery and supply of healthcare products and services for NHS trusts and healthcare organisations across England and Wales. TOS2 provides a single source for NHS Trusts to purchase orthopaedic products.
The NHS Supply Chain was initially designed to help the NHS deliver clinically assured, quality products at the best value. Therefore, the TOS2 agreement provides competitive national pricing and builds on TOS1, which secured over 50% of all spend in scope across the English NHS, with the aim of rising to over 90% with TOS2.
STIMULAN recently gained a new European CE mark approval for mixing with antibiotics: Vancomycin, gentamicin and tobramycin. It is the only calcium matrix approved for use in bone and soft tissue and targets high concentrations of antibiotic at the point of infection at levels unachievable systemically - which lowers rates of reinfection, saves hospital costs, and improves patient outcomes as a result.
Michael Harris, chief executive officer of Biocomposites, commented: “STIMULAN is already used in over 50,000 cases every year in thousands of hospitals around the world. As the only calcium sulfate antibiotic carrier approved for use in bone and soft tissue, our addition to TOS2 makes it even easier for hospitals and surgeons to access this breakthrough solution as part of their infection management strategy.”